BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30572728)

  • 1. New frontiers in precision medicine for sepsis-induced immunoparalysis.
    Bruse N; Leijte GP; Pickkers P; Kox M
    Expert Rev Clin Immunol; 2019 Mar; 15(3):251-263. PubMed ID: 30572728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options.
    Hamers L; Kox M; Pickkers P
    Minerva Anestesiol; 2015 Apr; 81(4):426-39. PubMed ID: 24878876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Immunotherapy for Sepsis.
    Peters van Ton AM; Kox M; Abdo WF; Pickkers P
    Front Immunol; 2018; 9():1926. PubMed ID: 30233566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological alterations in the endothelial barrier: a new predictive and therapeutic paradigm for sepsis.
    Feng J; Liu L; Liu J; Wang J
    Expert Rev Clin Immunol; 2024 Jun; ():1-13. PubMed ID: 38850066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis.
    Stolk RF; van der Poll T; Angus DC; van der Hoeven JG; Pickkers P; Kox M
    Am J Respir Crit Care Med; 2016 Sep; 194(5):550-8. PubMed ID: 27398737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal sepsis in the era of genomic medicine.
    Kouskouti C; Evangelatos N; Brand A; Kainer F
    Arch Gynecol Obstet; 2018 Jan; 297(1):49-60. PubMed ID: 29103195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Power of proteomics and progress in precision medicine - 13th central and eastern European proteomic conference (CEEPC), Ustroń, Poland.
    Gadher SJ; Widlak P; Kovarova H
    Expert Rev Proteomics; 2020 May; 17(5):335-340. PubMed ID: 32510255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics through the lens of precision cardiovascular medicine.
    Lam SM; Wang Y; Li B; Du J; Shui G
    J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Medicine Approach in Prostate Cancer.
    Assadi M; Jokar N; Ghasemi M; Nabipour I; Gholamrezanezhad A; Ahmadzadehfar H
    Curr Pharm Des; 2020; 26(31):3783-3798. PubMed ID: 32067601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics and the Microbiome as Biomarkers in Sepsis.
    Lee J; Banerjee D
    Crit Care Clin; 2020 Jan; 36(1):105-113. PubMed ID: 31733672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics as a Driver in Advancing Precision Medicine in Sepsis.
    Eckerle M; Ambroggio L; Puskarich MA; Winston B; Jones AE; Standiford TJ; Stringer KA
    Pharmacotherapy; 2017 Sep; 37(9):1023-1032. PubMed ID: 28632924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics for the future in asthma.
    Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
    Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.
    Leentjens J; Kox M; Koch RM; Preijers F; Joosten LA; van der Hoeven JG; Netea MG; Pickkers P
    Am J Respir Crit Care Med; 2012 Nov; 186(9):838-45. PubMed ID: 22822024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
    Valenti F; Falcone I; Ungania S; Desiderio F; Giacomini P; Bazzichetto C; Conciatori F; Gallo E; Cognetti F; Ciliberto G; Morrone A; Guerrisi A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the Road to Accurate Biomarkers for Cardiometabolic Diseases by Integrating Precision and Gender Medicine Approaches.
    Scola L; Giarratana RM; Torre S; Argano V; Lio D; Balistreri CR
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795333
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.